Nektar Therapeutics
NASDAQ:NKTR

Watchlist Manager
Nektar Therapeutics Logo
Nektar Therapeutics
NASDAQ:NKTR
Watchlist
Price: 0.9283 USD -1.35% Market Closed
Market Cap: 171.2m USD
Have any thoughts about
Nektar Therapeutics?
Write Note

Wall Street
Price Targets

NKTR Price Targets Summary
Nektar Therapeutics

Wall Street analysts forecast NKTR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NKTR is 4.794 USD with a low forecast of 1.313 USD and a high forecast of 7.35 USD.

Lowest
Price Target
1.313 USD
41% Upside
Average
Price Target
4.794 USD
416% Upside
Highest
Price Target
7.35 USD
692% Upside
Nektar Therapeutics Competitors:
Price Targets
600422
KPC Pharmaceuticals Inc
42% Upside
IPN
Ipsen SA
22% Upside
AHEALTH
Apex Healthcare Bhd
18% Upside
LQDA
Liquidia Corp
132% Upside
SNDL
Sundial Growers Inc
70% Upside
NEULANDLAB
Neuland Laboratories Ltd
31% Upside
SOLARA
Solara Active Pharma Sciences Ltd
12% Downside
4578
Otsuka Holdings Co Ltd
10% Upside

Revenue
Forecast

Revenue Estimate
Nektar Therapeutics

For the last 8 years the compound annual growth rate for Nektar Therapeutics's revenue is -11%. The projected CAGR for the next 4 years is 8%.

-11%
Past Growth
8%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Nektar Therapeutics

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-14%
Average Miss

Net Income
Forecast

Net Income Estimate
Nektar Therapeutics

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NKTR's stock price target?
Price Target
4.794 USD

According to Wall Street analysts, the average 1-year price target for NKTR is 4.794 USD with a low forecast of 1.313 USD and a high forecast of 7.35 USD.

What is Nektar Therapeutics's Revenue forecast?
Projected CAGR
8%

For the last 8 years the compound annual growth rate for Nektar Therapeutics's revenue is -11%. The projected CAGR for the next 4 years is 8%.

Back to Top